In a report released today, Lance Vitanza from TD Cowen reiterated a Buy rating on Compass Diversified Holdings (CODI – Research Report), with ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Gautam Khanna, analyst at TD Cowen, shares his outlook for Boeing and says it will take "a number of years" before the ...

TD Cowen upgraded Salesforce's ( NYSE: CRM) rating to Buy from Hold and raised the price target to $400 from $380. Shares of ...

TD Cowen analyst Bryan Bergin maintained a Hold rating on Paychex (PAYX – Research Report) today and set a price target of $146.00. The ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

Blue Owl Capital Inc (OWL) stock saw a modest uptick, ending the day at $23.4 which represents a slight increase of $0.49 or 2.14% from the prior close of $22.91. The stock opened at $23.15 and ...

Broadcom Inc (AVGO) stock saw a modest uptick, ending the day at $229.41 which represents a slight increase of $1.41 or 0.62% from the prior close of $228. The stock opened at $235.22 and touched a ...

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

And it goes without saying that we are living in very interesting times. Well, TD Cowen has released a report called "Themes for 2025," which digs into interesting themes like health care ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...